In October, 2008, the International Diabetes Federation (IDF) Clinical Guidelines Taskforce, in conjunction with the SMBG International Working Group, convened a workshop in Amsterdam to address the issue of SMBG utilization in people with type 2 diabetes (T2DM) that is not treated with insulin.Workshop participants included clinical investigators actively engaged in self-monitoring of blood glucose (SMBG) research and research translation activities.The purpose of the workshop was to:
Review the findings of selected key studies that describe the clinical and metabolic impact and the cost implica- tions of SMBG.
Identify additional studies and study designs that are needed to further define the role of SMBG in non- insulin-treated people with T2DM.
Propose recommendations for the use of SMBG in non-insulin-treated people with T2DM.
The following report presents a summary of the findings and recommendations related to the use of SMBG in people with non-insulin-treated type 2 diabetes.
Download Full Article: